|
IL264057B
(en)
|
|
Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
|
|
SMT201600430B
(it)
|
|
Inibitori di chinasi e loro uso nel trattamento del cancro
|
|
IL239007B
(en)
|
|
Eribulin for use in the treatment of breast cancer
|
|
SI2766040T1
(sl)
|
|
Pertuzumab, Trastuzumab, Docetaxel in Carboplatin za zdravljenje zgodnjega raka dojke
|
|
PT2768493T
(pt)
|
|
Fitocanabinoides para utilização no tratamento do cancro da mama
|
|
HUE036583T2
(hu)
|
|
Notch jelzõ folyamat inhibitorai és alkalmazásuk rákok kezelésében
|
|
PL3178849T3
(pl)
|
|
Kombinacja przeciwciał anty-lag-3 i przeciwciał anty-pd-1 w leczeniu raka
|
|
IL242386B
(en)
|
|
Use of Aribolin and Lavetinib as a combination therapy for cancer treatment
|
|
GB201115711D0
(en)
|
|
Phyto-cannabinoids for use in the treatment of cancer
|
|
IL238400A
(en)
|
|
Triazulophyrazines as brd4 inhibitors for use in cancer treatment
|
|
BR112014001440A2
(pt)
|
|
novas composições e métodos para o tratamento de câncer de próstata
|
|
HUE048876T2
(hu)
|
|
Rákos megbetegedések kezelése
|
|
PL2739153T3
(pl)
|
|
Leczenie raka sutka
|
|
IL253947A0
(en)
|
|
Methods of treating breast cancer with taxane therapy
|
|
HRP20190046T1
(hr)
|
|
Kombinirana terapija za liječenje raka
|
|
IL230698A0
(en)
|
|
Use of preparations containing crizotinib to treat cancer
|
|
IL226246A0
(en)
|
|
Methods of treating cancer
|
|
BR112014012495A2
(pt)
|
|
método in vitro, kit, inibidor de egfr e método de tratamento de pacientes afetados com câncer
|
|
AP3480A
(en)
|
|
Phosphaplatins and their use for treatment of cancers
|
|
PL2742356T3
(pl)
|
|
Środki prognostyczne w leczeniu nowotworów
|
|
BR112013028890A2
(pt)
|
|
composições e métodos para o tratamento de câncer
|
|
PL2948137T3
(pl)
|
|
Sposoby leczenia zwłóknienia i nowotworów
|
|
BR112014001430A2
(pt)
|
|
letalidade sintética e o tratamento do câncer
|
|
IL233080B
(en)
|
|
Bisarylsulfonamides used to treat inflammation and cancer
|
|
GB201412831D0
(en)
|
|
Detection and treatment of breast cancer
|